The Future…

By |2018-06-15T12:18:55+00:00July 25th, 2017|Categories: Industry Insights|Tags: , , , , , |

Introduction This month we’ve picked a somewhat broad topic for the blog: The future. What are some of the things that should be on the mind of the forward-thinking supplier of research use only reagents? Of course, this is largely and necessarily speculation, but hopefully somewhat informed! There are two general, interlinked areas to think [...]

ELISAs

By |2018-06-15T12:18:55+00:00June 26th, 2017|Categories: Industry Insights|Tags: , , , , , , , |

Introduction Among all the ligand bioassays developed, the one which has emerged victorious is the Enzyme Linked Immuno Assay, or ELISA. Variations on the ELISA now have to power to discriminate antigens down to the femtomole/femtogramme (10-18 of a kilogramme) level, depending on how it’s implemented, offering researchers unprecedented levels of sensitivity. Harnessing the power of [...]

Pivotal Scientific Antibody Market Report 2017

By |2017-09-22T15:49:42+00:00April 22nd, 2017|Categories: Industry Insights|Tags: , , , , |

Pivotal Scientific Antibody Market Report 2017   Pivotal Scientific is proud to have recently published its fifth annual Antibody Market Report. This year it indicates that there have been substantial changes in the antibody landscape between 2016 and 2017, with the global primary antibodies market growing in worth to $900 million, a significant slice of [...]

Comments Off on Pivotal Scientific Antibody Market Report 2017

3 reasons not to blame it on the Antibodies

By |2015-09-08T13:01:02+00:00September 8th, 2015|Categories: Antibody Suppliers|Tags: , , |

Antibodies have been pin pointed as the main culprit in the reproducibility issue surrounding the research reagents sector today. However is it too cynical and perhaps plain simplistic to place all the blame on the antibodies alone? Could it be that it is not just the antibodies that are the issue, but the way scientists [...]

Comments Off on 3 reasons not to blame it on the Antibodies

How alternative technologies may be key in future research methods

By |2017-09-22T14:52:59+00:00October 30th, 2014|Categories: Industry Insights|Tags: , |

Following the publication of the human genome it was assumed that life science research for health and disease was a fait accompli, with personalised medicine and a complete understanding of basic biology on the near horizon. Yet this hasn’t quite materialised. Despite definite advances in the life science field, being able to pinpoint and manipulate [...]

Comments Off on How alternative technologies may be key in future research methods
Do NOT follow this link or you will be banned from the site!